CAMBRIDGE, Mass., Oct. 11, 2018 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the BIO
Investor Forum on Wednesday, October 17,
2018, at 11:15 a.m. PT
(2:15 p.m. ET) in San Francisco, CA. A live webcast of the
presentation will be available on the Investors/Media section of
Infinity's website at www.infi.com, and will be available for 30
days following the event.
About Infinity
Infinity is an innovative
biopharmaceutical company dedicated to advancing novel cancer
treatments. Infinity is advancing IPI-549, a potentially
transformative immuno-oncology approach that aims to reprogram
tumor-associated macrophages by selectively inhibiting PI3K-gamma.
A Phase 1/1b study in approximately
200 patients with advanced solid tumors is ongoing. For more
information on Infinity, please refer to Infinity's website at
www.infi.com.
Contact:
Stephanie
Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com
View original
content:http://www.prnewswire.com/news-releases/infinity-to-present-at-bio-investor-forum-300729176.html
SOURCE Infinity Pharmaceuticals, Inc.